Food News and Research

RSS

Opinion: Fighting world hunger; U.S. leadership on global issues

In a USA Today column, writer DeWayne Wickham examines the connection between hunger and global security. "Helping poor countries feed their hungry masses is not just a grand humanitarian gesture; it is good diplomacy — a refreshing change from the jingoism and dollar diplomacy of previous administrations," he writes.

22 Oct 2009

Also in Global Health News: Nigeria Global Fund grant; Pakistani refugees; Guinea violence

The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. "During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and former Head of State, General Yakubu Gowon, disclosed that the [The Global Fund] had spent $15.6 billion in 140 countries worldwide especially in Africa to support large scale prevention treatment and care programmes against these diseases.

22 Oct 2009

CWRU establishes collaborative research center to address common health issues in urban neighborhoods

Case Western Reserve University (CWRU) School of Medicine proudly announces the establishment of the CWRU Prevention Research Center for Healthy Neighborhoods (PRCHN), a collaborative research center to address common health issues faced in disadvantaged urban neighborhoods in and around Greater Cleveland.

22 Oct 2009

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).

21 Oct 2009

FDA grants Fast Track designation for MacuSight's Perceiva

MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today announced that it has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME).

21 Oct 2009

Shire to file a Biologics License Application for REPLAGAL with the FDA

Shire plc, the global specialty biopharmaceutical company, announces plans to file a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease, by the end of the year.

21 Oct 2009

King Pharmaceuticals receives FDA complete response letter for CorVue NDA

King Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for CorVue™ (binodenoson) for injection.

21 Oct 2009

APHA urges Americans to be prepared for any kind of emergency

Setting the clocks on Nov. 1 because of daylight saving time gives us a little extra time to think about preparing for emergencies. Since Mother Nature is known to throw us a curveball when we least expect it, the American Public Health Association is urging Americans to be ready for any kind of emergency such as blizzards, floods, blackouts or influenza.

21 Oct 2009

U.S. food aid policy to be more flexible, Clinton, Vilsack say

"The Obama administration wants more flexibility in how it allocates food aid dollars to complement its new strategy to help small farmers in poor countries boost their food production," according to a conference call Friday with Secretary of State Hillary Clinton and Agriculture Secretary Tom Vilsack, Reuters reports.

21 Oct 2009

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Chlorothiazide Sodium for Injection, USP. APP expects to launch Chlorothiazide Sodium for Injection, USP in the fourth quarter of 2009.

21 Oct 2009

Summit to highlight multi-system interoperability and transparency for safer US food supply chain

Colorado-based Traceability Institute announced today the dates of the first executive summit designed to initiate consensus to achieve multi-system interoperability with the goal of accomplishing a more sustainable and safer US food supply chain.

21 Oct 2009

U.S. Pharmacopeial fellowships awarded to 6 students

New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.

21 Oct 2009

D2 Pharma Consulting develops "REMS Challenges and Real World Solutions" White Paper

D2 Pharma Consulting LLC (D2) is a best-in-class national consulting company that works with pharmaceutical and biotech manufacturers on the implementation of REMS compliant distribution programs, in addition to other commercialization activities. D2 structures REMS distribution programs on behalf of their clients that leverage supply chain efficiencies while complying with FDA mandates.

21 Oct 2009

Monsanto enters into a collaboration with Huazhong Agricultural University

Monsanto Company and Huazhong Agricultural University have entered into a collaboration to further the development of novel traits such as higher yield, drought resistance and nitrogen use efficiency. Monsanto will evaluate and advance certain technologies developed by Professor Qifa Zhang's research team at Huazhong Agricultural University in China.

21 Oct 2009

FDA purchases Waters ACQUITY UPLC Systems for protecting the U.S. food supply

Waters Corporation announced today that the U.S. Food and Drug Administration's Center for Food Safety and Applied Nutrition (CFSAN), College Park, MD recently purchased nine Waters® ACQUITY UltraPerformance LC® (UPLC®) Systems to support its priority to protect the U.S. food supply by monitoring domestically-produced and imported food sold in interstate commerce.

21 Oct 2009

Abbott acquires Visiogen; expands vision care business

Abbott today announced that it has completed its acquisition of privately held eye care company Visiogen, expanding the company's vision care business with a next-generation accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients.

21 Oct 2009

Lactose intolerance rates may be overestimated by wide margins

Prevalence of lactose intolerance may be far lower than previously estimated, according to a study in the latest issue of Nutrition Today.(1) The study, which uses data from a national sample of three ethnic groups, reveals that the overall prevalence rate of self-reported lactose intolerance is 12 percent - with 7.72 percent of European Americans, 10.05 percent of Hispanic Americans and 19.5 percent of African Americans who consider themselves lactose intolerant.

21 Oct 2009

IOM: More fruits and vegetables should be included in school meal programs

The United Fresh Produce Association applauds the Institute of Medicine’s School Meals: Building Blocks for Healthy Children Report released today. Increasing both the amount and the variety of vegetables and fruits that schools offer in meals is one of IOM’s top recommendations contained in the report for improving the healthfulness of school meals.

21 Oct 2009

Genomes of two E. coli bacteria strains sequenced and analyzed

An international team of researchers from the United States, Korea, and France has sequenced and analyzed the genomes of two important laboratory strains of E. coli bacteria, one used to study evolution and the other to produce proteins for basic research or practical applications. The findings will help guide future research and will also open a window to a deeper understanding of classical research that is the foundation of our understanding of basic molecular biology and genetics.

21 Oct 2009

Bill & Melinda Gates Foundation's initiative to transform health in developing countries

The Bill & Melinda Gates Foundation today announced 76 grants of US$100,000 each to pursue bold ideas for transforming health in developing countries. The grants support researchers across 16 countries, including nine in Europe and Africa with ideas as diverse as using the power of sunlight to kill malaria-causing mosquito larvae and developing a device that repels mosquitoes without insecticides.

21 Oct 2009